Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort
Authors:
- 19 January 2024
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 26 (5) , 101076
Abstract
No abstract availableKeywords
Funding Information
- NHGRI
- NHMRC
- Australian Genomics Health Alliance
This publication has 37 references indexed in Scilit:
- De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residuesHuman Genetics, 2023
- Targeted long-read sequencing identifies missing disease-causing variationThe American Journal of Human Genetics, 2021
- De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathyHuman Mutation, 2020
- Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental DisordersThe American Journal of Human Genetics, 2020
- A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in Ill InfantsThe American Journal of Human Genetics, 2019
- Mendelian Gene Discovery: Fast and Furious with No End in SightThe American Journal of Human Genetics, 2019
- Fetal diagnosis of Mowat‐Wilson syndrome by whole exome sequencingAmerican Journal of Medical Genetics Part A, 2019
- A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian DisordersHuman Mutation, 2015
- GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same GeneHuman Mutation, 2015
- Discovery and Statistical Genotyping of Copy-Number Variation from Whole-Exome Sequencing DepthThe American Journal of Human Genetics, 2012